FDA Inspection 1122522 — Charles River Laboratories Cleveland, Inc.
The FDA completed an inspection of Charles River Laboratories Cleveland, Inc. on Feb 19, 2020 in Cleveland, OH. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Feb 19, 2020
- Fiscal Year
- 2020
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Cleveland, OH (United States)